MedPage Today on MSN1d
For Your Patients: Know the Symptoms of Multiple MyelomaWhile there is no cure for multiple myeloma, increased awareness about the symptoms can be the key to timely diagnosis and ...
Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...
The study highlights the importance of including patient self-assessment—and not just clinician assessment—when planning ...
A new research paper was published in Oncotarget, Volume 16, on March 21, 2025, titled “NSD2-epigenomic reprogramming and ...
News-Medical.Net on MSN1d
Breakthrough study links NSD2 gene to plasma cell identity in myelomaA new research paper was published in Oncotarget , Volume 16, on March 21, 2025, titled "NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma." Researchers Andrea ...
More than half of patients recently diagnosed with lymphoma or myeloma had clinically significant symptoms of anxiety or ...
A Spanish study that investigated the prognostic value of immunophenotyping in patients with multiple myeloma has found that expression of the antigens CD19, CD28 and CD117 are significantly ...
Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.
Our findings suggest a role for NSD2 in maintaining MM cell identity, with potential implications for future therapeutic strategies based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback